Podcast Episodes
Back to Search
Anti-TIGIT Therapy: Overview of Current Clinical Evidence and Key Ongoing Trials
Episode 121
In this episode, Jyoti D. Patel, MD, and Ani Balmanoukian, MD, discuss several studies investigating agents targeting TIGIT, an emerging immune check…
4 years, 2 months ago
Targeting TIGIT: Understanding New Approaches for Inhibiting the Immune Checkpoint Pathway
Episode 120
In this episode, Jyoti D. Patel, MD, and Diwakar Davar, MD, discuss several studies investigating agents targeting TIGIT, an emerging immune checkpoi…
4 years, 2 months ago
Evolving Treatment Landscape With Regorafenib and TAS-102 in Metastatic Colorectal Cancer
Episode 119
In this episode, Nilofer S. Azad, MD, and Kanwal Raghav, MD, discuss current and emerging uses of regorafenib and TAS-102 in later-line treatment of …
4 years, 2 months ago
Expert Answers to Key Questions on Current and Emerging BTK Inhibitor Therapies for CLL and MCL
Episode 118
In this episode, Jeff P. Sharman, MD; Matthew S. Davids, MD, MMSc; and Anthony Mato, MD, MSCE, answer questions from a live CCO webinar on current be…
4 years, 3 months ago
Expert Insights on Optimal Current Management of Patients With Cholangiocarcinoma
Episode 117
In this episode, Lipika Goyal, MD, leads an engaging discussion with Christine Chio, PharmD, BCOP, and Caroline Kuhlman, NP, on current treatment of …
4 years, 3 months ago
Cancer Conversations: 3 Case Challenges of Real Patients With Myelodysplastic Syndromes
Episode 116
In this podcast episode, Amy DeZern, MD, MHS, Daniel Pollyea, MD, MS, and Amer Zeidan, MBBS, discuss challenging cases in MDS, including
Treatment for…4 years, 3 months ago
Expert Insights on Targeted Therapies for Advanced Systemic Mastocytosis
Episode 115
In this episode, Dr Prithviraj Bose, Pharmacist Caitlin R. Rausch, and Nurse Practitioner Ilene A. Galinsky discuss incorporating KIT-targeted therap…
4 years, 3 months ago
Advances in B-Cell Lymphomas: Understanding Current Treatment Approaches
Episode 114
In this episode, Julie M. Vose, MD, MBA; Brad S. Kahl, MD; and John P. Leonard, MD, discuss treatment approaches for patients with B-cell lymphomas…
4 years, 4 months ago
TKIs for Advanced HCC in the Second Line and Beyond
Episode 113
In this podcast episode from Clinical Care Options (CCO), Josep M. Llovet, MD, PhD, and Markus Peck-Radosavljevic, MD, MBA, discuss second line treat…
4 years, 4 months ago
New Directions With PARP Inhibitors in Pancreatic Cancer
Episode 112
In this episode, Eileen M. O’Reilly, MD, and Naureen Starling, MD, FRCP, discuss emerging therapeutic strategies involving PARP inhibitor therapy in…
4 years, 4 months ago